Last 7 days
1.0%
Last 30 days
-8.0%
Last 90 days
-36.8%
Trailing 12 Months
-71.8%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
LYB | 28.2B | 47.5B | -8.34% | -19.49% | 9.28 | 0.59 | -5.39% | -48.13% |
PPG | 26.8B | 17.7B | -4.21% | 4.38% | 24.98 | 1.52 | 2.87% | 18.13% |
IFF | 19.9B | 12.2B | -19.34% | -40.77% | -10.7 | 1.63 | -1.42% | -768.10% |
WLK | 15.1B | 15.1B | -4.69% | -17.30% | 6.74 | 0.96 | 12.00% | -25.52% |
RPM | 10.3B | 7.2B | -2.77% | -11.41% | 19.52 | 1.42 | 11.69% | 17.31% |
MID-CAP | ||||||||
OLN | 6.4B | 8.8B | -11.23% | -25.87% | 5.85 | 0.73 | -7.34% | -24.77% |
AXTA | 5.3B | 5.0B | -5.10% | 7.77% | 26.11 | 1.1 | 10.33% | -27.28% |
NEU | 3.8B | 2.8B | -1.18% | 17.82% | 11.96 | 1.36 | 14.40% | 76.05% |
SXT | 3.2B | 1.5B | -2.01% | -16.73% | 22.49 | 2.2 | 5.41% | 10.73% |
GCP | 2.4B | - | 1.27% | 44.25% | 215.39 | 2.37 | - | - |
SMALL-CAP | ||||||||
WLKP | 809.2M | 1.5B | -4.59% | -19.92% | 10.8 | 0.56 | 17.52% | -46.24% |
FF | 393.9M | 427.9M | 20.00% | 23.63% | 8.09 | 0.92 | 27.12% | 91.20% |
AMRS | 277.1M | 268.2M | -8.05% | -71.84% | -0.52 | 1.03 | 20.46% | -95.04% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Revenue | -0.6% | 268,221,000 | 269,847,000 | 258,821,000 | 235,558,000 | 222,667,000 |
S&GA Expenses | -2.2% | 482,583,000 | 493,629,000 | 453,126,000 | 399,052,000 | 326,805,000 |
R&D Expenses | 0.4% | 110,622,000 | 110,215,000 | 105,958,000 | 101,002,000 | 97,315,000 |
Costs and Expenses | 7.1% | 898,173,000 | 838,830,000 | 803,838,000 | 719,242,000 | 617,799,000 |
EBITDA | -71.1% | -313,100,000 | -182,997,000 | -62,647,000 | - | - |
EBITDA Margin | -55.7% | -1.21 | -0.78 | -0.28 | - | - |
Earnings Before Taxes | -17.1% | -630,997,000 | -538,625,000 | -351,102,000 | -218,064,000 | -92,187,000 |
EBT Margin | -46.5% | -1.36 | -0.93 | -0.44 | - | - |
Interest Expenses | 31.2% | 32,453,000 | 24,733,000 | 27,604,000 | 25,636,000 | 25,055,000 |
Net Income | -55.0% | -528,510,000 | -340,868,000 | -212,417,000 | -87,023,000 | - |
Net Income Margin | -46.0% | -1.32 | -0.90 | -0.39 | - | - |
Free Cahsflow | -12.6% | -575,187,000 | -511,021,000 | -442,426,000 | - | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Assets | -17.6% | 680 | 825 | 754 | 789 | 898 |
Current Assets | -20.5% | 244 | 306 | 272 | 310 | 471 |
Cash Equivalents | -72.9% | 17.00 | 64.00 | 18.00 | 100 | 288 |
Inventory | -2.6% | 109 | 112 | 129 | 99.00 | 82.00 |
Net PPE | 4.1% | 190 | 182 | 170 | 151 | 125 |
Goodwill | -64.6% | 50.00 | 143 | 127 | 134 | 1.00 |
Liabilities | 2.7% | 1,328 | 1,293 | 1,159 | 1,033 | 1,024 |
Current Liabilities | 21.6% | 471 | 387 | 309 | 187 | 266 |
LT Debt, Current | 2.7% | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 |
LT Debt, Non Current | 0.1% | 676 | 675 | 674 | 673 | 672 |
Shareholder's Equity | -35.9% | -664 | -488 | - | - | - |
Retained Earnings | -6.0% | -3,073 | -2,900 | -2,730 | -2,568 | -2,458 |
Additional Paid-In Capital | 0.4% | 2,466 | 2,456 | 2,384 | 2,357 | - |
Accumulated Depreciation | 2.3% | 99.00 | 96.00 | 95.00 | - | - |
Shares Outstanding | 1.0% | 369 | 365 | 325 | 321 | 309 |
Minority Interest | 24.4% | -9.76 | -12.91 | -13.10 | -6.60 | -3.52 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Cashflow From Operations | 11.9% | -463 | -525 | -575 | -511 | -442 |
Share Based Compensation | -11.9% | 43.00 | 49.00 | 48.00 | 45.00 | 41.00 |
Cashflow From Investing | 34.3% | -81.24 | -123 | -142 | -147 | -108 |
Cashflow From Financing | 16.3% | 269 | 231 | 626 | 550 | 698 |
100%
94.2%
93.8%
Y-axis is the maximum loss one would have experienced if Amyris was unfortunately bought at previous high price.
-33.6%
-29.4%
-32%
-41.4%
FIve years rolling returns for Amyris.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-05-26 | ProShare Advisors LLC | reduced | -7.07 | -6,857 | 32,568 | -% |
2023-05-26 | SHEETS SMITH WEALTH MANAGEMENT | sold off | -100 | -82,836 | - | -% |
2023-05-22 | AMERIPRISE FINANCIAL INC | reduced | -8.44 | -6,741 | 27,259 | -% |
2023-05-22 | Arete Wealth Advisors, LLC | reduced | -7.92 | -19,301,800 | 16,000 | -% |
2023-05-18 | NEW YORK STATE COMMON RETIREMENT FUND | reduced | -73.96 | -142,000 | 43,000 | -% |
2023-05-18 | JPMORGAN CHASE & CO | reduced | -22.46 | -1,004,000 | 2,226,000 | -% |
2023-05-17 | Advisory Services Network, LLC | unchanged | - | -21.00 | 170 | -% |
2023-05-17 | B. Riley Wealth Advisors, Inc. | unchanged | - | -12,631 | 101,048 | -% |
2023-05-16 | CVI Holdings, LLC | sold off | -100 | -27,791,800 | - | -% |
2023-05-16 | IMA Wealth, Inc. | unchanged | - | -42.00 | 340 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
May 24, 2023 | foris ventures, llc | 29.9% | 120,177,411 | SC 13D/A | |
Mar 17, 2023 | foris ventures, llc | 30.1% | 119,877,165 | SC 13D/A | |
Feb 14, 2023 | cvi investments, inc. | 4.9% | 18,163,117 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 5.84% | 21,211,189 | SC 13G/A | |
Feb 07, 2023 | farallon capital partners, l.p. | 0.0% | 64,221 | SC 13G/A | |
Jan 09, 2023 | foris ventures, llc | 33.5% | 119,710,362 | SC 13D/A | |
Jan 04, 2023 | cvi investments, inc. | 5.5% | 2e+07 | SC 13G | |
Dec 16, 2022 | dsm international b.v. | - | 0 | SC 13D/A | |
Sep 15, 2022 | foris ventures, llc | 28.0% | 96,051,761 | SC 13D/A | |
Sep 08, 2022 | foris ventures, llc | 27.5% | 93,989,044 | SC 13D/A |
Date Filed | Form Type | Document | |
---|---|---|---|
May 26, 2023 | 8-K | Current Report | |
May 24, 2023 | SC 13D/A | 13D - Major Acquisition | |
May 10, 2023 | 10-Q | Quarterly Report | |
May 09, 2023 | 8-K | Current Report | |
Apr 24, 2023 | EFFECT | EFFECT | |
Apr 24, 2023 | EFFECT | EFFECT | |
Apr 24, 2023 | 8-K | Current Report | |
Apr 21, 2023 | 4 | Insider Trading | |
Apr 21, 2023 | 4 | Insider Trading | |
Apr 21, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-04-19 | Panchadsaram Ryan | acquired | - | - | 9,667 | - |
2023-04-19 | MCCANN JAMES F | acquired | - | - | 13,437 | - |
2023-04-19 | Qi Lisa | acquired | - | - | 10,537 | - |
2023-04-19 | DOERR L JOHN | acquired | - | - | 11,600 | - |
2023-04-05 | ALVAREZ EDUARDO | sold | -284,305 | 1.2288 | -231,368 | chief operating officer |
2023-04-04 | ALVAREZ EDUARDO | acquired | - | - | 492,000 | chief operating officer |
2023-01-20 | Qi Lisa | acquired | - | - | 7,532 | - |
2023-01-20 | Panchadsaram Ryan | acquired | - | - | 7,947 | - |
2023-01-20 | MCCANN JAMES F | acquired | - | - | 9,605 | - |
2023-01-20 | DOERR L JOHN | acquired | - | - | 8,292 | - |
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2023 | Mar. 31, 2022 | |
Revenue: | ||
Revenue | $ 56,083 | $ 57,709 |
Cost and operating expenses: | ||
Cost of products sold | 51,081 | 48,995 |
Research and development | 26,765 | 26,358 |
Sales, general and administrative | 95,870 | 106,916 |
Change in fair value of acquisition-related contingent consideration | (28,503) | 0 |
Restructuring | 1,013 | 0 |
Impairment | 95,386 | 0 |
Total cost and operating expenses | 241,612 | 182,269 |
Loss from operations | (185,529) | (124,560) |
Other income (expense): | ||
Interest expense | (12,983) | (5,263) |
Gain from change in fair value of derivative instruments | 1,263 | 1,815 |
(Loss) gain from change in fair value of debt | (4,854) | 20,796 |
Other expense, net | (533) | (3,052) |
Total other (expense) income, net | (17,107) | 14,296 |
Loss before income taxes and loss from investment in affiliate | (202,636) | (110,264) |
Benefit from income taxes | 860 | 820 |
Loss from investment in affiliate | 0 | (789) |
Net loss | (201,776) | (110,233) |
Loss attributable to noncontrolling interest | 8,434 | 2,928 |
Net loss attributable to Amyris, Inc. common stockholders | $ (193,342) | $ (107,305) |
Earnings Per Share [Abstract] | ||
Net loss per share attributable to common stockholders, basic (in dollars per share) | $ (0.53) | $ (0.34) |
Weighted-average shares of common stock outstanding used in computing net loss per share of common stock, basic (in shares) | 365,603,738 | 312,896,452 |
Net loss per share attributable to common stockholders, diluted (in dollars per share) | $ (0.53) | $ (0.37) |
Weighted-average shares of common stock outstanding used in computing net loss per share of common stock, diluted (in shares) | 365,603,738 | 323,711,682 |
Renewable Products | ||
Revenue: | ||
Revenue | $ 40,224 | $ 43,465 |
Licenses and Royalties | ||
Revenue: | ||
Revenue | 9,482 | 9,313 |
Collaborations, Grants and Other | ||
Revenue: | ||
Revenue | $ 6,377 | $ 4,931 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 11,245 | $ 64,437 |
Restricted cash | 71 | 71 |
Accounts receivable, net of allowance of $997 and $995 | 36,842 | 45,775 |
Accounts receivable - related party, net of allowance of $0 and $0 | 10,836 | 6,608 |
Contract assets | 3,872 | 806 |
Contract assets - related party | 33,679 | 36,638 |
Inventories | 109,021 | 111,880 |
Prepaid expenses and other current assets | 38,095 | 40,146 |
Total current assets | 243,661 | 306,361 |
Property, plant and equipment, net | 189,645 | 182,224 |
Restricted cash, noncurrent | 6,135 | 6,090 |
Recoverable taxes from Brazilian government entities | 30,189 | 29,472 |
Right-of-use assets under financing leases, net | 147 | 152 |
Right-of-use assets under operating leases, net | 100,721 | 97,216 |
Goodwill | 50,456 | 142,575 |
Intangible assets, net | 45,063 | 46,938 |
Other assets | 13,662 | 13,904 |
Total assets | 679,679 | 824,932 |
Current liabilities: | ||
Accounts payable | 200,067 | 190,486 |
Accrued and other current liabilities | 81,068 | 73,565 |
Financing lease liabilities | 14 | 13 |
Operating lease liabilities | 2,484 | 2,255 |
Contract liabilities | 33 | 26 |
Debt, current portion | 1,968 | 1,916 |
Related party debt, current portion | 185,160 | 118,886 |
Total current liabilities | 470,794 | 387,147 |
Long-term debt, net of current portion | 675,855 | 674,891 |
Related party debt, net of current portion | 77,962 | 97,350 |
Financing lease liabilities, net of current portion | 44 | 48 |
Operating lease liabilities, net of current portion | 90,986 | 86,195 |
Derivative liabilities | 4,140 | 5,403 |
Acquisition-related contingent consideration | 2,241 | 34,555 |
Other noncurrent liabilities | 5,725 | 7,053 |
Total liabilities | 1,327,747 | 1,292,642 |
Commitments and contingencies | ||
Mezzanine equity: | ||
Contingently redeemable common stock | 0 | 5,000 |
Contingently redeemable noncontrolling interest | 26,058 | 28,892 |
Stockholders’ (deficit) equity: | ||
Common stock - $0.0001 par value, 550,000,000 shares authorized as of March 31, 2023 and December 31, 2022; 368,524,240 and 364,745,266 shares issued and outstanding as of March 31, 2023 and December 31, 2022 | 37 | 36 |
Additional paid-in capital | 2,465,802 | 2,455,567 |
Accumulated other comprehensive loss | (56,682) | (64,114) |
Accumulated deficit | (3,073,520) | (2,880,178) |
Total Amyris, Inc. stockholders’ (deficit) equity | (664,363) | (488,689) |
Noncontrolling interest | (9,763) | (12,913) |
Total stockholders' (deficit) equity | (674,126) | (501,602) |
Total liabilities, mezzanine equity and stockholders' (deficit) equity | $ 679,679 | $ 824,932 |